This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Rule
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories; Correction
This correction is effective March 5, 2024, and is applicable beginning January 27, 2024.
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
FederalRegister.gov retrieves relevant information about this document
from Regulations.gov to provide users with additional context. This
information is not part of the official Federal Register document.
Clinical Laboratory Improvement Amendments Fees: Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories (CMS-3326-P)
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
540
as of
07/11/2026 at 6:15 am EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2024-04590 as it appeared on Public Inspection on
03/04/2024 at 8:45 am.
It was viewed
79
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2024-04590 (89 FR 15755)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
( printed page 15755)
AGENCY:
Centers for Medicare & Medicaid Services (CMS) and Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Final rule; correction.
SUMMARY:
This document corrects technical and typographical errors in the final rule that appeared in the December 28, 2023,
Federal Register
entitled, “Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories” (referred to hereafter as the “December 2023 final rule”).
DATES:
This correction is effective March 5, 2024, and is applicable beginning January 27, 2024.
In FR Doc. 2023-28170 of December 28, 2023, the December 2023 final rule (88 FR 89976), there were technical and typographical errors that are identified and corrected in this correcting document. These corrections are applicable beginning January 27, 2024, as if they had been included in the December 2023 final rule.
II. Summary of Errors
On page 89985, in the first footnote to the table titled, “TABLE 4: Examples, Two-part Increase per Certificate Type”, we inadvertently included incorrect amounts for the current and updated Certificate of Registration (CoR) fees. As stated in the proposed rule that appeared in the July 26, 2022,
Federal Register
entitled, “Clinical Laboratory Improvement Amendments of 1988 (CLIA) Fees; Histocompatibility, Personnel, and Alternative Sanctions for Certificate of Waiver Laboratories”, the correct current CoR fee was $100. With application of the one-time across-the-board (ATB) increase of 18 percent along with the biennial two-part fee increase of 4.9598 percent, the correct updated fee amount is $123.
Similarly on page 90027, in the table titled, “TABLE 17: Two-part Biennial Certificate Fee”, in the Certificate of Registration (CoR) row, we inadvertently included incorrect amounts in the “Current fee” and “New average fee” columns. We are correcting as described previously.
On page 90028, in the table titled, “TABLE 18: CLIA Replacement and Revised Certificates FY 2019”, we made typographical errors in the “Cost of Revised Certificate” entries for the Certificate of Accreditation (CoA) and Certificate for Provider-performed Microscopy (PPM) certificate types. The amounts were reversed in the table. The corrected certificate fees for each of these revised certificate types corresponds to the fees in Table 6, “CMS Proposed Fee for Issuance of Revised Certificate” in the final rule.
III. Waiver of Proposed Rulemaking and Delay in Effective Date
Under 5 U.S.C. 553(b) of the Administrative Procedure Act (APA), the agency is required to publish a notice of the proposed rulemaking in the
Federal Register
before the provisions of a rule take effect. Section 553(d) of the APA ordinarily requires a 30-day delay in effective date of final rules after the date of their publication in the
Federal Register
.
Section 553(b)(B) of the APA authorizes an agency to dispense with normal rulemaking requirements for good cause if the agency makes a finding that the notice and comment process is impracticable, unnecessary, or contrary to the public interest. In addition, section 553(d)(3) of the APA allows the agency to avoid the 30-day delay in effective date where such delay is contrary to the public interest and an agency includes a statement of support.
We believe this correcting document does not constitute a rule that would be subject to the notice and comment or delayed effective date requirements. This document merely corrects technical and typographical errors in the December 2023 final rule but does not make substantive changes to the policies that were adopted in the December 2023 final rule. Instead, this correcting document is intended to ensure that the information in the December 2023 final rule accurately reflects the policies adopted in that document.
In addition, even if this were a rule to which the notice and comment procedures and delayed effective date requirements applied, we find that there is good cause to waive such requirements. Undertaking further notice and comment procedures to incorporate the corrections in this document into the December 2023 final rule or delaying the effective date would be contrary to the public interest because it is in the public's interest to ensure that the December 2023 final rule accurately reflects the policies finalized in that final rule. Furthermore, such procedures would be unnecessary, as we are not altering our policies, but rather, we are simply correctly implementing the policies we finalized. This final rule correction is intended to ensure that the December 2023 final rule accurately reflects those policies. Therefore, we believe we have good cause to waive the notice and comment and delayed effective date requirements.
1. On page 89985, in the first footnote to the table titled, “TABLE 4: Examples, Two-part Increase per Certificate Type”, the language that reads, “Note: The Certificate of Registration (CoR) fee would increase from the $150 to $184.” is corrected to read, “Note: The Certificate of Registration (CoR) fee would increase from the $100 to $123.”
2. On page 90027, in the table titled, “TABLE 17: Two-part Biennial Certificate Fee”, the last row that reads:
( printed page 15756)
Table 17—Two-Part Biennial Certificate Fee
Type of CLIA Certificate
Laboratory schedule
Current fee (c)
New average (n)
ATB and
biennial
increase
= 18% * 4.96%
Number of
laboratories *
Number of
laboratories
divided by
2 **
Certificate of Registration (CoR)
Not applicable
$150
$184
2891
1,445.5
is corrected to read:
Table 17—Two-Part Biennial Certificate Fee
Type of CLIA Certificate
Laboratory schedule
Current fee (c)
New average (n)
ATB and
biennial
increase
= 18% * 4.96%
Number of
laboratories *
Number of
laboratories
divided by
2 **
Certificate of Registration (CoR)
Not applicable
$100
$123
2891
1,445.5
3. On page 90028, in the table titled, “TABLE 18: CLIA Replacement and Revised Certificates FY 2019”, rows 4 and 5 that read:
Table 18—CLIA Replacement and Revised Certificates FY2019 *
Certificate
type
Number of
replacement
certificates
issued in FY2019
Cost of
replacement
certificate
Number of revised
certificates
issued in
FY2019
Cost of
revised
certificate
CoA
496
$75
505
$150
PPM
525
75
984
95
are corrected to read:
Table 18—CLIA Replacement and Revised Certificates FY2019 *
Certificate
type
Number of
replacement
certificates
issued in FY2019
Cost of
replacement
certificate
Number of revised
certificates
issued in
FY2019
Cost of
revised
certificate
CoA
496
$75
505
$95
PPM
525
75
984
150
Elizabeth J. Gramling,
Executive Secretary to the Department, Department of Health and Human Services.